Pharmaceutical m-Health
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Pharmaceutical m-Health

on

  • 1,117 views

This conference shall address the numerous ways in which the pharmaceutical industry specifically can contribute to, and benefit from the increasing mobility of healthcare.The global telemedicine ...

This conference shall address the numerous ways in which the pharmaceutical industry specifically can contribute to, and benefit from the increasing mobility of healthcare.The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015, and therefore represents a major opportunity.

The vast potential for mobile phones to change everyday life with their increasing technological capacity to connect people and systems over vast distances, send and receive larger amounts of information, and operate from ever more advanced platforms, affects people and businesses in a variety of ways. Healthcare is certainly no exception, and there are several areas of the pharmaceutical industry that are either undergoing fundamental changes to accommodate and gain from this mobility, or are about to.

Statistics

Views

Total Views
1,117
Views on SlideShare
1,117
Embed Views
0

Actions

Likes
0
Downloads
31
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Pharmaceutical m-Health Document Transcript

  • 1. REGISTER BY 30TH JUNE AND RECEIVE A £300 DISCOUNT SMi present ... Pharmaceutical m-Health Monday 10th & Tuesday 11th October 2011 The Grange Holborn Hotel, London KEY SPEAKERS INCLUDE: Kai Gait Digital Commerce Marketing Manager GSK Martina Flammer Senior Medical Director Pfizer Ken Grady Global Head, Business Intelligence & Commercial IT Novartis Vaccines and Diagnostics Pēteris Zilgalvis Head of Unit, Governance and Ethics European Commission The impact that increasingly Iain Cranston Consultant Diabetes Physician, Intensive Therapy and Pump Service, sophisticated mobile technology Queen Alexandra Hospital is having on the pharmaceuticals Paul Berney CMO and MD EMEA industry is becoming clearer. Mobile Marketing Association m-Health has great potential to open new markets, cut costs, and CONFERENCE HIGHLIGHTS: • Learn about the way physicians use smartphones, and what this save lives. This conference will means for pharma products • Analyse current mobile enabled anti-counterfeiting projects in highlight the ways in which pharma developing markets • Discuss the potential for tele-monitoring to revolutionise clinical trials can contribute to and benefit from • Debate the real business value of investment to pharma and maximising ROI this growing industry. • Hear from mobile technology providers themselves PLUS A HALF-DAY POST-CONFERENCE WORKSHOP Wednesday 12th October 2011, The Grange Holborn Hotel, London Sponsored by Internal governance and m-Health Facilitated by: Patricia Barnfather, Communications Consultant, Barnfather Consulting Daniel Ghinn, Healthcare Engagement Strategy Consultant, Creation Healthcare Gary Monk, Managing Director, Across Group 8.30am-12.30pmwww.smi-online.co.uk/m-health.aspRegister online and receive full information on all of SMi’s conferencesAlternatively fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711
  • 2. Pharmaceutical m-HealthDay One | Monday 10th October 2011 www.smi-online.co8.30 Registration and Coffee 1.25 Collaborative work in developing markets between pharma, technology providers and governmental organisations9.00 Chairmans opening remarks • Pfizer’s work with the UN and Vodaphone in developing countries Robert Istepanian, Professor of Data Communication, Director of • Developing markets and mhealth Mobile Information and Network Technologies, Kingston University • Pharma’s role in contributing to better product information in developing countries Martina Flammer, Senior Medical Director, Pfizer9.10 eHealth in Europe: at the convergence of technology, medicine, law and society 2.00 PANNEL DISCUSSION • Over the past 20 years, the European Commission has seen eHealth – Adapting to the advent of mobile technology in pharma develop from a niche research area into an important policy priority. • Discussion about the various applications – The realities of their application • This evolution has brought complex technological and legal issues • The increasing permeability of the line between consumer, into the sensitive domains of health and society. physician and pharma • The European Commissions approach to eHealth and its vision for • Enabling cross industry relationships: Consumer healthcare and the coming years. technology providers example • The ramifications for mHealth of the EC’s initiatives in Innovation • Establishing the real ways ROI can be achieved Union and the Digital Agenda for Europe. David Saint Denis, Director, Organizational Efficiency Emerging Pēteris Zilgalvis, Head of Unit for ICT for Health in DG INFSO, European Markets GBU, Merck Serono Commission Luke Raskino, Global New Business Unit Director, Unilever Jamie Driver, Business Development Manager, Medhand International BlackBerry speaker9.45 Where does mobile fit for Pharma industry, healthcare professionals and patients MOBILE TECHNOLOGY PROVIDERS • Is mobile that important? • Is it an app, mobile web or both 2. 35 Mobile data: delivering data at the point of need • What do you really deliver – a vanity app or useful tools • Case study: how BlackBerry has been deployed within the Kai Gait, Digital Commerce Marketing Manager, GSK Health/Pharmaceutical sector • How can mobile data help increase efficiencies and effectiveness10.20 Morning Coffee • Building the business case: explore the business benefits that can be delivered10.40 How mHealth is transforming the patient experience & the Pharma Presentation by BlackBerry industry opportunity 3.15 Afternoon Tea • What are the big mHealth opportunities • Why is Mobile Video so transformational? 3.35 The future of mobile internet – Pharma and its role • Whats happening already and wheres the evidence? • Electronic innovation in pharma; from communication to collaboration • Whats next? • Measureable benefits to existing systems David Doherty, coFounder, 3G Doctor • Success stories in mhealth Paul Jones, Director and Co-Leader of Global Life Sciences, Cisco DEVELOPING MARKETS 4.10 Enabling an ecosystem of connected health solutions through11.15 mHealth: The Indian Scenario interoperability • India, stated to be a superpower by 2025, now has a teledensity of • Achievements of the Continua Health Alliance • The impact on mobile health solutions 65% and 92% of this is through mobile phone • Opportunities in the development of pharmaceutical products • Indians are embracing mobiles with 30% having smart phones Frank Wartena, Technical Working Group Vice Chair, Continua • The exponential adoption of mBanking, mCommerce & Healthcare Alliance Research Scientist, Philips Research Europe mEntertainment suggests that mHealth cannot be far behind • How mHealth may be the only answer to 750 million Indians living in 4.45 The future of mobile internet – Pharma and its role suburban and rural India who have no or very limited access to • Electronic innovation in pharma; from communication to collaboration secondary and tertiary medical care • Measureable benefits to existing systems Krishnan Ganapathy, President, Apollo Telemedicine Networking • Success stories in mhealth Foundation, President, Telemedicine Society of India Paul Jones, Director and Co-Leader of Global Life Sciences, Cisco11.50 Anti counterfeiting: How m-health can enable secure medication in 5.20 Chairman’s Closing Remarks developing countries 5.30 Drinks reception hosted by BlackBerry • Utilising the mobile health care network to protect patients and Please join us for a drinks reception pharma companies alike at the end of the first day. This will be • The current SMS code system a relaxed and social setting for you to • How this can be built upon network with conference participants Bright Simons, Chief Strategist, MPedigree and to follow up any questions you may Stefan Prebil, Lead Strategist, MPedigree have with speakers from the event.12.25 Networking Lunch 7.00 Close of Day Two Register online at www.smi-online.co.uk/m-health.asp • Alternativel Sponsored by BlackBerry® is the leading wireless communications solution that keeps mobile health professionals securely connected to colleagues and operational data. BlackBerry is delivering tangible efficiencies and improvements in business processes to organisations in the health and pharmaceutical sector that are helping to deliver substantial cost savings. As well as the built in wireless applications like e-mail, personal organizer and phone, BlackBerry devices are being used by mobile health professionals to access key clinical and corporate data systems. Supported by
  • 3. Pharmaceutical m-Healtho.uk/m-health.asp Day Two | 11th October 2011 8.30 Re-registration and Coffee 12.25 Networking Lunch 9.00 Chairmans opening remarks THE APPLICATIONS OF PHARMACEUTICAL M-HEALTH David Doherty, coFounder, 3G Doctor 1.25 Next generation sales force: go mobile, go fast HEALTHCARE PROFESSIONALS • Engaging physicians and health care professionals with mobile enabled toolsets 9.10 m-Health in diabetes care, shaping data into clinical information for • Business Intelligence in your pocket – transparent, real-time, anywhere clinical change data that makes a difference • There are a plethora of m-Health platforms for monitoring diabetes • Connecting a distributed workforce, creating new sources of field available across the UK and worldwide intelligence • To realise the potential benefits of the technology requires both an • Less to carry, tangible improvements in visit frequency effective data collection platform, a display and analysis module that Ken Grady, Global Head, Business Intelligence & Commercial IT, Novartis facilitates effective communication and also a change in a standard Vaccines and Diagnostics model of care to support clarity, decision making and therapy change. 2.00 Mobile comes of age: the role of the mobile channel in pharma • Clinical insights from the use of such m-Health platforms and the • The drivers for mobile marketing changes required to consulting practices to support their effective • The international trends inclusion in the patient : HCP consultation process • How to creating a strategy for mobile Iain Cranston, Consultant Diabetes Physician, Intensive Therapy and Pump Paul Berney, CMO and MD EMEA, Mobile Marketing Association Service, Queen Alexandra Hospital 2. 35 Raising revenues by putting the patient in control 9.45 Facilitating communication between pharma and the healthcare industry • Value-added services are possible through patient-controlled medical • A dual perspective: Current status and processes records • The increasing use of mobile devices by healthcare professionals • Payers are switching to paying for outcomes not pills, so pharmaceutical • Apps and beyond: How pharma-physician communications can be companies must monitor and improve compliance facilitated • Research costs are lower and data quality is higher when patients • The value of product information to pharma and healthcare professionals consent to use their working clinical records alike • Mobile user interfaces are key to patient engagement in these services Joelle Sissmann, Former VP Global Product Communications, Sanofi- Mohammad Al-Ubaydli, CEO, Patients Know Best Aventis; Cardiologist, Cardiac Rehabilitation Unit, Hopital Corentin Celton 3.10 Afternoon Tea 10.20 Morning Coffee 3.30 How effective use of Mheatlh changes relationships between Pharma 10.40 M-health via community pharmacists - the need and case studies from companies, healthcare workers and ultimately patients. the MoMed group • How Mhealth changes the traditional engagement between • Department of health’s latest recommendations support the expanded Pharma > Doctors, Pharma > Patient role of community pharmacists in the management of long term • How this replicates around the globe paying particular attention to any conditions variance in 1st & 2nd World nations. (Pharma companies have great • Importance of providing support to patients receiving treatment at home opportunities for social responsibility in developing nations) • M-health Exemplars and Case studies from the MoMed group • How present efforts will affect the future Shereen Nabhani-Gebara, Senior lecturer in pharmacy practice, Kingston Jamie Driver, Business Development Manager, Medhand International University Nada Philip, Senior Lecturer, (CISM) Kingston University 4.05 How m-Health can boost clinical trial patient recruitment, retention and compliance. Ala Mohammed Husain Sungoor, Researcher(CISM) Kingston University • How mobile can help you communicate better with patients. • How capturing patient information via mobile can enhance your data 11.15 Leveraging mobile to deliver information and choice quality. • Why is Mobile integral to NHS Choices in reaching & engaging citizens • How mobile applications can save your staff time • Health Services via SMS. mobile & apps Tim Benjamin, Managing Director, TreatmentTrials.com • Success stories • Digital convergence and reaching the digitally excluded 4.40 Breaking down barriers: A review of the main barriers to digital within Richard Moore, Senior Digital Manager, Digital Marketing, NHS Choices pharma and some practical steps to overcome them • The top 3 barriers to digital implementation within pharma are, 11.50 How doctors are using smart phones (1) Regulatory concerns (2) Lack of a digital strategy (3) ROI questions • iPhone apps – a Pharma vanity project or clinical value? • With the right approach these barriers can be overcome • Which specialties have adapted technology the fastest • Experience some practical examples of how to do this • What doctors are saying about mobile Gary Monk, Managing Director, Across Group Carwyn Jones, Head of Pharmaceutical Sales and Marketing, Doctors.net.uk 5.15 Chairman’s Closing Remarks and Close of Day Twoly fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711 Who should attend this conference? SPONSORSHIP AND EXHIBITION OPPORTUNITIES SMi offer sponsorship, exhibition, advertising and branding Executive Directors, Vice Presidents, Heads, Managers, Team leaders of packages, uniquely tailored to complement your company’s the following roles: marketing strategy. Prime networking opportunities exist • Mhealth • Emerging Media • Web Design to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. • Telehealth • Marketing, • Content Management Should you wish to join the increasing number of companies • Digital Communications • eMarketing, • Brand Management benefiting from sponsoring our conferences please call: • Clinical Trials • Digital Marketing, • Product Marketing, Product Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi- • Recruitment and Retention • Multi-Channel Marketing Development online.co.uk • CRM • PR • Compliance Want to know how you can get involved? • e-Detailing • Communications, • Business Development Interested in promoting your pharmaceutical services to • Social Media, • eCommunications, • Risk Management this market? • Online Media, • Communications Research • Global Product Contact Kiran Sharma, SMi Marketing on +44 (0)20 7827 6050, • eMedia , • eBusiness Communications or email: ksharma@smi-online.co.uk
  • 4. HALF-DAY POST-CONFERENCE AM WORKSHOP Wednesday 12th October 2011 8.30am – 12.30pm The Grange Holborn Hotel, London Internal Governance in m-HealthOverview of workshopAlong with the numerous advantages that m-health can potentiallyoffer the pharmaceutical industry, comes the challenge ofincorporating the usage of this new technology into existinggovernance frameworks. With regulatory bodies currentlydeveloping their stance on the lines that can and cannot be crossedwith pharma apps, now is a critical time for the industry toinvestigate into the alterations they will have to make to internalgovernance in order to be prepared for the coming changes, anddevelop new codes of conduct.In this session, one of the most interactive that SMi have everproduced, participants will thoroughly explore the pros and cons ofdifferent models by analysing different frameworks, presentingideas to a critical panel, and even completing a pre workshopsurvey to better inform the proceedings.Workshop agenda8.30 Registration and coffee9.00 Welcome and introduction9.10 Knowing what you don’t know • Review of relevant EU and country specific regulations • Establishing a set of key governance principals • Analysis of delegate responses to preconference survey9.30 How to get approval and stay sane • Each of the three leaders will give a 15 minute presentation on their experiences • Different governance models, what works, doesn’t work and could work better10.15 Coffee10.45 Practical working session to create or improve your existing governance model • Participants will split into groups for a moderated break-out session to share existing models • Discuss pros and cons, and come up with suggestions for an improved system that encourages and enables innovation11.45 Sanity checking your governance model through the lens of internal clients • Group exercise where volunteers present their draft models to a cross-functional panel • Group leaders will comment from a legal, medical, corporate affairs and marketing perspective • Open discussion12.30 Workshop closeAbout the workshop facilitators: Patricia Barnfather is an independent consultant with over 17 years healthcare expertise working in-house and agency. After gaining an MSc in Public Relations at Stirling University, she worked for Countrywide Porter Novelli and Cohn & Wolfe before joining Eli Lilly and Company to lead the UK communications team. She worked at Eli Lilly and Company for over 10years in product, corporate and internal communications and mostrecently in the Global Channel Development Team as a consultantto the business on improving customer engagement through newand traditional communication channels. As part of this role, sheestablished a cross-functional governance process for socialmedia projects. Daniel Ghinn is co-founder of Creation Healthcare, a consultancy that helps people in pharmaceutical and healthcare organizations to increase their effectiveness in a changing environment. His work with global healthcare businesses has resulted in improved outcomes from engagement with patients and healthcare professionals using emergingcommunications channels, and cost savings through improvedcross-functional collaboration. Daniel is an international speaker,teacher, and writer and is editor of Healthcare EngagementStrategy, an e-journal documenting how emerging channels arechanging healthcare engagement. During the last 6 years, Gary Monk has worked in various Brand Management and e-Business roles at Johnson & Johnson. His outstanding achievements have been consistently recognised across the industry; he recently won the PM Society 2010 Digital Pioneer award and in 2009 he was bestowed a Pharmatimes Marketer of the Year award, his brandhaving won 5 awards at the previous PM digital awards. Theseaccolades recognize his success in an array of innovative digitalprojects and the delivery of strong business results, including arevolutionary multichannel physician campaign that measurablyincreased share in the target segment and a pioneering patientawareness campaign that delivered 130,000 targeted views andallowed comments on Youtube
  • 5. PHARMACEUTICALFORWARD PLANNER June 2011 01/02 Pain Therapeutics 27/28 RNAi, miRNA, siRNA 29/30 Pharmaceutical Portfolio & Product Life Cycle Management 29/30 Pharmaceutical Nanotechnology 29/30 KOL Management and MSL Best Practice in Europe (Munich, Germany) July 2011 06/07 ADMET 06/07 Social Media in the Pharmaceutical Industry 11/12 BioBanking 18/19 Pharmaceutical and Clinical Trial Logistics Asia Pacific (Singapore) 20/21 Pre Filled Syringes Asia (Singapore) September 2011 19/20 Biomarkers in Clinical Trials 26/27 Biosimilars and Biobetters 28/29 KOL Knowledge Leaders October 2011 03/04 Partnerships with CROs 10/11 Pharmaceutical m-Health 12/13 GP Commissioning 19/20 COPD: Novel Therapeutics and Management Strategies 24/25 Point of Care Diagnostics - Market Opportunities and Technology Trends November 2011 31 Oct/1 Nov European Pharmaceutical Pricing & Reimbursement (Switzerland) 16/17 Clinical Trials in CNS 21/22 Cell Based Assay December 2011 5/6 Cold Chain Distribution All conferences take place in central London, UK – unless indicated otherwise in brackets ABOUT THE SMi PHARMACEUTICAL TEAM SMi have been involved in the pharmaceutical industry since 1993 and have developed a series of informative and niche events, covering the latest issues and developments surrounding the industry. Events bring together senior industry professionals and serving companies who have a focus on being at the forefront of developments in this area. SMi aim to generate informed and topical discussion through the medium of both conferences and executive briefings. Our pharmaceutical events are research-based and content driven with regular contact with major industry personnel and cover a wide range of industry sectors. For more information, please visit www.smi- online.co.uk/pharma
  • 6. PHARMACEUTICAL M-HEALTH Conference: Monday 10th and Tuesday 11th October 2011, The Grange Holborn Hotel, London, UK Workshop: Wednesday 12th October 2011, London 4 WAYS TO REGISTER www.smi-online.co.uk/m-health.aspFAX your booking form to +44 (0) 870 9090 712 POST your booking form to: Events Team, SMi Group Ltd, Great GuildfordPHONE on +44 (0) 870 9090 711 Business Square, 30 Great Guildford Street London, SE1 0HS, UK EARLY BIRD □ Book by 30th June to receive £300 off the conference price DISCOUNT CONFERENCE PRICES I would like to attend: (Please tick as appropriate) Fee Total □ Conference & Half-Day Workshop £1998.00 + VAT £2397.60 □ Conference only £1399.00 + VAT £1678.80Unique Reference Number □ Half-Day Workshop £599.00 + VAT £718.80 PROMOTIONAL LITERATURE DISTRIBUTIONOur Reference LVP-036 □ Distribution of your company’s promotionalDELEGATE DETAILS literature to all conference attendees £999.00 + VAT £1198.80Please complete fully and clearly in capital letters. Please photocopy for additional delegates. GROUP DISCOUNTS AVAILABLETitle: Forename: The conference fee includes refreshments, lunch, conference papers and accessSurname: to the Document Portal containing all of the presentations.Job Title:Department/Division: VENUE The Grange Holborn Hotel, 50-60 Southampton Row, London WC1B 4ARCompany/Organisation:Email: □ Please contact me to book my hotel Alternatively call us on +44 (0) 870 9090 711,Address: email: hotels@smi-online.co.uk or fax +44 (0) 870 9090 712Town/City: DOCUMENTATIONPost/Zip Code: Country: I cannot attend but would like to purchase access to the following DocumentDirect Tel: Direct Fax: Portal/paper copy documentation Price TotalMobile: □ Access to the conference documentation on the Document Portal £499.00 + VAT £598.80Switchboard: □ The Conference Presentations – paper copy £499.00 - £499.00Signature: Date: (or only £300 if ordered with the Document Portal)I agree to be bound by SMis Terms and Conditions of Booking.ACCOUNTS DEPT PAYMENTTitle: Forename: Payment must be made to SMi Group Ltd, and received before the event, by one of theSurname: following methods quoting reference P-036 and the delegate’s name. Bookings made within 7 days of the event require payment on booking, methods of payment are below. PleaseEmail: indicate method of payment:Address (if different from above): □ UK BACS Sort Code 300009, Account 00936418 □ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU Swift (BIC): LOYDGB21013, Account 00936418 IBAN GB48 LOYD 3000 0900 9364 18Town/City: □ Cheque We can only accept Sterling cheques drawn on a UK bank.Post/Zip Code: Country: □ Credit Card □ Visa □ MasterCard □ American Express All credit card payments will be subject to standard credit card charges.Direct Tel: Direct Fax: Card No: □□□□ □□□□ □□□□ □□□□Terms and Conditions of Booking Valid From □□/□□ Expiry Date □□/□□ CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX cardPayment: If payment is not made at the time of booking, then an invoice will be issued and must bepaid immediately and prior to the start of the event. If payment has not been received then credit carddetails will be requested and payment taken before entry to the event. Bookings within 7 days ofevent require payment on booking. Access to the Document Portal will not be given until paymenthas been received. Cardholder’s Name:Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, anotherdelegate to take your place at any time prior to the start of the event. Two or more delegates maynot ‘share’ a place at an event. Please make separate bookings for each delegate. Signature: Date:Cancellation: If you wish to cancel your attendance at an event and you are unable to send a I agree to be bound by SMis Terms and Conditions of Booking.substitute, then we will refund/credit 50% of the due fee less a £50 administration charge,providing that cancellation is made in writing and received at least 28 days prior to the start of the Card Billing Address (If different from above):event. Regretfully cancellation after this time cannot be accepted. We will however provide theconferences documentation via the Document Portal to any delegate who has paid but is unable toattend for any reason. Due to the interactive nature of the Briefings we are not normally able toprovide documentation in these circumstances. We cannot accept cancellations of orders placedfor Documentation or the Document Portal as these are reproduced specifically to order. If we haveto cancel the event for any reason, then we will make a full refund immediately, but disclaim anyfurther liability.Alterations: It may become necessary for us to make alterations to the content, speakers, timing,venue or date of the event compared to the advertised programme.Data Protection: The SMi Group gathers personal data in accordance with the UK Data ProtectionAct 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other VATproducts and services. Unless you tick here □ we may also share your data with third partiesoffering complementary products or services. If you have any queries or want to update any of the VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on Documentdata that we hold then please contact our Database Manager databasemanager@smi-online.co.uk Portal and Literature Distribution for all UK customers and for those EU customers not supplyingor visit our website www.smi-online.co.uk/updates quoting the URN as detailed above youraddress on the attached letter. a registration number for their own country here: ______________________________________ If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at events@smi-online.co.uk